Bodycote
BOY · Main Market · Industrial Goods and Services · mcap £1,542m · 910.0p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 28 Sep 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
−3.1% | |
| 28 Sep 26 | Publication of Scheme Document
Scheme document published for Veritas Capital's recommended cash acquisition of Bodycote; shareholder meetings on 21 October 2026. |
−3.1% | |
| 28 Sep 26 | Statement of intention not to make an offer
CVC confirms it does not intend to make an offer for Bodycote following previous takeover approach. |
−3.1% | |
| 24 Sep 26 | Board change | Directorate Change
Emmanuelle Dubu appointed Remuneration Committee Chair; Cynthia Gordon steps down from Board. |
−0.3% |
| 02 Sep 26 | Suspension of Share Buyback Programme
Bodycote suspends £80m share buyback programme following Veritas Capital recommended cash offer announcement. |
+0.1% | |
| 01 Sep 26 | Offer | Statement Regarding Possible Offer
CVC Advisers considering position regarding possible offer for Bodycote following Veritas Offer announcement. |
+4.6% |
| 01 Sep 26 | Offer | Recommended Cash Acquisition of Bodycote plc
Veritas Capital to acquire Bodycote for 940 pence per share in cash, a 36.5% premium to pre-offer price. |
+4.6% |
| 05 Aug 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
+23.1% | |
| 05 Aug 26 | Offer | Statement Regarding Possible Offers for Bodycote
Board receives two conditional takeover proposals from CVC at 915p per share and Veritas at 914p per share. |
+23.1% |
| 28 Jul 26 | Dividend notification
Further to the announcement of the Company's 2026 Interim Results released on 28 July 2026, the Company announces a correction to the record date for the interim dividend. |
+0.1% | |
| 28 Jul 26 | Results | 2026 Interim Results
H1 revenue up 3.3% to £381.2m, organic growth 6.5%; adjusted operating profit up 10.7% to £61.0m. |
+0.1% |
| 05 Jun 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
−13.1% | |
| 05 Jun 26 | Response to statement by Apollo
Apollo confirms it will not make a firm offer for Bodycote; offer period ends. |
−13.1% | |
| 05 Jun 26 | Rule 2.8 Announcement
Apollo withdraws conditional proposal for Bodycote and states no intention to make firm offer. |
−13.1% | |
| 27 May 26 | Trading in line with expectations - FY26 outlook maintained
Four-month trading shows 9.0% Core revenue growth; FY26 outlook maintained despite geopolitical uncertainty. |
−0.8% | |
| 22 May 26 | Disclosure Table
The following are today's changes to the Disclosure Table: |
+19.0% | |
| 22 May 26 | Response to media speculation
Apollo proposes conditional cash offer of 885 pence per share plus final dividend of 16.1 pence. |
+19.0% | |
| 16 Apr 26 | Results | Annual Report
Further to the Company’s announcement of Full Year Results 2025 issued on 11 March 2026, Bodycote plc announces that it has today published its 2025 Annual Report and Accounts (2025 Annual Report) and Notice of 2026 Annu |
+1.2% |
| 27 Mar 26 | Board change | Directorate Change
Bodycote, the world's leading provider of heat treatment and specialist thermal processing services, hereby notifies that Cynthia Gordon, has informed the Board of her intention to step down as Non-Executive Director and |
−3.5% |
| 11 Mar 26 | Launch of new £80 million Share Buyback Programme
Bodycote launches £80 million share buyback programme to be completed by end of 2027. |
+7.9% | |
| 11 Mar 26 | Results | Final Results
FY25 revenue down 4% to £727.1m, adjusted operating profit fell 11.4% to £114.3m, but Core revenue broadly stable with H2 momentum improving. |
+7.9% |
| 16 Jan 26 | Acquisition Of Spectrum Thermal Processing
Bodycote acquires Spectrum Thermal Processing, a US heat treatment provider, for $8m cash. |
+0.3% | |
| 21 Nov 25 | Completion of disposal of ten Non-Core sites in France
Bodycote completes sale of ten non-core French heat treatment sites to Arcole for €22m. |
−0.2% | |
| 18 Nov 25 | Divisional re-statement for enhanced Optimise programme
Bodycote re-states divisional structure following expanded Optimise programme scope affecting 30 plants. |
+0.2% | |
| 18 Nov 25 | Trading update | November Trading Update
Core revenue grew 2.2% organically in four months to October; Group revenue down 2.7% year-to-date despite improved momentum. |
+0.2% |
Company filings. Not investment advice.